185 related articles for article (PubMed ID: 38467827)
21. Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer.
Yang R; Zeng Y; Xu H; Chen Z; Xiang M; Fu Y; Yin Y; Zhong J; Zeng M; Wang P; You Q; Zeng X
Oncol Rep; 2016 Aug; 36(2):929-35. PubMed ID: 27278897
[TBL] [Abstract][Full Text] [Related]
22. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
[TBL] [Abstract][Full Text] [Related]
23. Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
Shan Z; Wang W; Tong Y; Zhang J
Med Sci Monit; 2021 Mar; 27():e929558. PubMed ID: 33758160
[TBL] [Abstract][Full Text] [Related]
24. Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancer.
Deng J; Liang H; Zhang R; Hou Y; Liu Y; Ying G; Pan Y; Hao X
Br J Surg; 2016 Mar; 103(4):407-16. PubMed ID: 26805552
[TBL] [Abstract][Full Text] [Related]
25. Identification of a prognostic 28-gene expression signature for gastric cancer with lymphatic metastasis.
Zhang C; Jing LW; Li ZT; Chang ZW; Liu H; Zhang QM; Zhang QY
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30971501
[TBL] [Abstract][Full Text] [Related]
26. Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival.
Cui J; Xi H; Cai A; Ma L; Bian S; Zhang K; Wei B; Chen L
Clin Lab; 2016; 62(6):993-1001. PubMed ID: 27468560
[TBL] [Abstract][Full Text] [Related]
27. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer.
Yin J; Lv X; Hu S; Zhao X; Liu Q; Xie H
Hum Pathol; 2019 Mar; 85():10-17. PubMed ID: 30500416
[TBL] [Abstract][Full Text] [Related]
29. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
30. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
[TBL] [Abstract][Full Text] [Related]
31. FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.
Hou XL; Ji CD; Tang J; Wang YX; Xiang DF; Li HQ; Liu WW; Wang JX; Yan HZ; Wang Y; Zhang P; Cui YH; Wang JM; Bian XW; Liu W
Sci Rep; 2017 Jun; 7(1):3153. PubMed ID: 28600569
[TBL] [Abstract][Full Text] [Related]
32. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
33. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis.
Fang W; Cui H; Yu D; Chen Y; Wang J; Yu G
Med Oncol; 2014 Jul; 31(7):15. PubMed ID: 24924473
[TBL] [Abstract][Full Text] [Related]
35. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer.
Huo J; Wu L; Zang Y
J Immunol Res; 2021; 2021():5554342. PubMed ID: 34007851
[TBL] [Abstract][Full Text] [Related]
37. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
38. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
39. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
[TBL] [Abstract][Full Text] [Related]
40. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
